Drug Eluting Balloon for Peripheral Artery Disease Market 2027 by Drug Coating Technology, End-Users and Geography | The Insight Partners

Drug Eluting Balloon for Peripheral Artery Disease Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Drug Coating Technology (Paccocath, Endurocoat, Freepac, Lutonix, Stellarex); End-Users (Hospitals, Ambulatory Surgery Centers, Catheterization Laboratories, Others)and Geography

Report Code: TIPRE00008457 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Covid
MARKET INTRODUCTION

Drug-eluting balloons (DEB) are conventional semi-compliant angioplasty balloons covered with an anti-proliferative drug which is released into the vessel wall during inflation of the balloon, usually at nominal pressures with a specific minimal inflation time. Drug- eluting balloons (DEB) for Peripheral Artery Disease have been introduced to improve patency rates following endovascular intervention for lower extremity PAD (Peripheral Artery Disease)

MARKET DYNAMICS

The factors that drive the Global Drug Eluting Balloon for Peripheral Artery Disease Market includes rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral artery disease. For instance, according to Centre for Disease Control and Prevention, approximately 8.5 million people age 40 and older in the United States have PAD. However, stringent regulatory background may impede the market growth.

MARKET SCOPE

`
The "Global Drug Eluting Balloon for Peripheral Artery Disease Market analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Drug Eluting Balloon for Peripheral Artery Disease Market with detailed market segmentation by drug coating technology, end-users and geography. The Global Drug Eluting Balloon for Peripheral Artery Disease Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Drug Eluting Balloon for Peripheral Artery Disease Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Global Drug Eluting Balloon for Peripheral Artery Disease Market is segmented on the basis of drug coating technology, and end-users. On the basis of drug coating technology, the market is segmented into Paccocath, Endurocoat, Freepac, Lutonix, Stellarex. Based on end-users the market is segment into, hospitals, ambulatory surgery centers, catheterization laboratories, and others ?


REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Drug Eluting Balloon for Peripheral Artery Disease Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Drug Eluting Balloon for Peripheral Artery Disease Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Drug Eluting Balloon for Peripheral Artery Disease market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Drug Eluting Balloon for Peripheral Artery Disease Market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Drug Eluting Balloon for Peripheral Artery Disease Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Drug Eluting Balloon for Peripheral Artery Disease Market are anticipated to lucrative growth opportunities in the future with the rising demand for Drug Eluting Balloon for Peripheral Artery Disease Market in the global market. Below mentioned is the list of few companies engaged in the Drug Eluting Balloon for Peripheral Artery Disease Market.

The report also includes the profiles of key Drug Eluting Balloon for Peripheral Artery Disease Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Medtronic
- Koninklijke Philips N.V.
- BD
- Cook Medical
- MEDRAD, INC. (Bayer HealthCare's)
- Eurocor
- Cardionovum

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Drug Eluting Balloon For Peripheral Artery Disease Market - By Drug Coating Technology
1.3.2 Drug Eluting Balloon For Peripheral Artery Disease Market - By End-Users
1.3.3 Drug Eluting Balloon For Peripheral Artery Disease Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DRUG ELUTING BALLOON FOR PERIPHERAL ARTERY DISEASE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DRUG ELUTING BALLOON FOR PERIPHERAL ARTERY DISEASE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. DRUG ELUTING BALLOON FOR PERIPHERAL ARTERY DISEASE MARKET - GLOBAL MARKET ANALYSIS
6.1. DRUG ELUTING BALLOON FOR PERIPHERAL ARTERY DISEASE - GLOBAL MARKET OVERVIEW
6.2. DRUG ELUTING BALLOON FOR PERIPHERAL ARTERY DISEASE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. DRUG ELUTING BALLOON FOR PERIPHERAL ARTERY DISEASE MARKET - REVENUE AND FORECASTS TO 2027 - DRUG COATING TECHNOLOGY
7.1. OVERVIEW
7.2. DRUG COATING TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. PACCOCATH
7.3.1. Overview
7.3.2. Paccocath Market Forecast and Analysis
7.4. ENDUROCOAT
7.4.1. Overview
7.4.2. Endurocoat Market Forecast and Analysis
7.5. FREEPAC
7.5.1. Overview
7.5.2. Freepac Market Forecast and Analysis
7.6. LUTONIX
7.6.1. Overview
7.6.2. Lutonix Market Forecast and Analysis
7.7. STELLAREX
7.7.1. Overview
7.7.2. Stellarex Market Forecast and Analysis
8. DRUG ELUTING BALLOON FOR PERIPHERAL ARTERY DISEASE MARKET - REVENUE AND FORECASTS TO 2027 - END-USERS
8.1. OVERVIEW
8.2. END-USERS MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. AMBULATORY SURGERY CENTERS
8.4.1. Overview
8.4.2. Ambulatory Surgery Centers Market Forecast and Analysis
8.5. CATHETERIZATION LABORATORIES
8.5.1. Overview
8.5.2. Catheterization Laboratories Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. DRUG ELUTING BALLOON FOR PERIPHERAL ARTERY DISEASE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Drug Eluting Balloon For Peripheral Artery Disease Market Overview
9.1.2 North America Drug Eluting Balloon For Peripheral Artery Disease Market Forecasts and Analysis
9.1.3 North America Drug Eluting Balloon For Peripheral Artery Disease Market Forecasts and Analysis - By Drug Coating Technology
9.1.4 North America Drug Eluting Balloon For Peripheral Artery Disease Market Forecasts and Analysis - By End-Users
9.1.5 North America Drug Eluting Balloon For Peripheral Artery Disease Market Forecasts and Analysis - By Countries
9.1.5.1 United States Drug Eluting Balloon For Peripheral Artery Disease Market
9.1.5.1.1 United States Drug Eluting Balloon For Peripheral Artery Disease Market by Drug Coating Technology
9.1.5.1.2 United States Drug Eluting Balloon For Peripheral Artery Disease Market by End-Users
9.1.5.2 Canada Drug Eluting Balloon For Peripheral Artery Disease Market
9.1.5.2.1 Canada Drug Eluting Balloon For Peripheral Artery Disease Market by Drug Coating Technology
9.1.5.2.2 Canada Drug Eluting Balloon For Peripheral Artery Disease Market by End-Users
9.1.5.3 Mexico Drug Eluting Balloon For Peripheral Artery Disease Market
9.1.5.3.1 Mexico Drug Eluting Balloon For Peripheral Artery Disease Market by Drug Coating Technology
9.1.5.3.2 Mexico Drug Eluting Balloon For Peripheral Artery Disease Market by End-Users
9.2. EUROPE
9.2.1 Europe Drug Eluting Balloon For Peripheral Artery Disease Market Overview
9.2.2 Europe Drug Eluting Balloon For Peripheral Artery Disease Market Forecasts and Analysis
9.2.3 Europe Drug Eluting Balloon For Peripheral Artery Disease Market Forecasts and Analysis - By Drug Coating Technology
9.2.4 Europe Drug Eluting Balloon For Peripheral Artery Disease Market Forecasts and Analysis - By End-Users
9.2.5 Europe Drug Eluting Balloon For Peripheral Artery Disease Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Drug Eluting Balloon For Peripheral Artery Disease Market
9.2.5.1.1 Germany Drug Eluting Balloon For Peripheral Artery Disease Market by Drug Coating Technology
9.2.5.1.2 Germany Drug Eluting Balloon For Peripheral Artery Disease Market by End-Users
9.2.5.2 France Drug Eluting Balloon For Peripheral Artery Disease Market
9.2.5.2.1 France Drug Eluting Balloon For Peripheral Artery Disease Market by Drug Coating Technology
9.2.5.2.2 France Drug Eluting Balloon For Peripheral Artery Disease Market by End-Users
9.2.5.3 Italy Drug Eluting Balloon For Peripheral Artery Disease Market
9.2.5.3.1 Italy Drug Eluting Balloon For Peripheral Artery Disease Market by Drug Coating Technology
9.2.5.3.2 Italy Drug Eluting Balloon For Peripheral Artery Disease Market by End-Users
9.2.5.4 Spain Drug Eluting Balloon For Peripheral Artery Disease Market
9.2.5.4.1 Spain Drug Eluting Balloon For Peripheral Artery Disease Market by Drug Coating Technology
9.2.5.4.2 Spain Drug Eluting Balloon For Peripheral Artery Disease Market by End-Users
9.2.5.5 United Kingdom Drug Eluting Balloon For Peripheral Artery Disease Market
9.2.5.5.1 United Kingdom Drug Eluting Balloon For Peripheral Artery Disease Market by Drug Coating Technology
9.2.5.5.2 United Kingdom Drug Eluting Balloon For Peripheral Artery Disease Market by End-Users
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Drug Eluting Balloon For Peripheral Artery Disease Market Overview
9.3.2 Asia-Pacific Drug Eluting Balloon For Peripheral Artery Disease Market Forecasts and Analysis
9.3.3 Asia-Pacific Drug Eluting Balloon For Peripheral Artery Disease Market Forecasts and Analysis - By Drug Coating Technology
9.3.4 Asia-Pacific Drug Eluting Balloon For Peripheral Artery Disease Market Forecasts and Analysis - By End-Users
9.3.5 Asia-Pacific Drug Eluting Balloon For Peripheral Artery Disease Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Drug Eluting Balloon For Peripheral Artery Disease Market
9.3.5.1.1 Australia Drug Eluting Balloon For Peripheral Artery Disease Market by Drug Coating Technology
9.3.5.1.2 Australia Drug Eluting Balloon For Peripheral Artery Disease Market by End-Users
9.3.5.2 China Drug Eluting Balloon For Peripheral Artery Disease Market
9.3.5.2.1 China Drug Eluting Balloon For Peripheral Artery Disease Market by Drug Coating Technology
9.3.5.2.2 China Drug Eluting Balloon For Peripheral Artery Disease Market by End-Users
9.3.5.3 India Drug Eluting Balloon For Peripheral Artery Disease Market
9.3.5.3.1 India Drug Eluting Balloon For Peripheral Artery Disease Market by Drug Coating Technology
9.3.5.3.2 India Drug Eluting Balloon For Peripheral Artery Disease Market by End-Users
9.3.5.4 Japan Drug Eluting Balloon For Peripheral Artery Disease Market
9.3.5.4.1 Japan Drug Eluting Balloon For Peripheral Artery Disease Market by Drug Coating Technology
9.3.5.4.2 Japan Drug Eluting Balloon For Peripheral Artery Disease Market by End-Users
9.3.5.5 South Korea Drug Eluting Balloon For Peripheral Artery Disease Market
9.3.5.5.1 South Korea Drug Eluting Balloon For Peripheral Artery Disease Market by Drug Coating Technology
9.3.5.5.2 South Korea Drug Eluting Balloon For Peripheral Artery Disease Market by End-Users
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Drug Eluting Balloon For Peripheral Artery Disease Market Overview
9.4.2 Middle East and Africa Drug Eluting Balloon For Peripheral Artery Disease Market Forecasts and Analysis
9.4.3 Middle East and Africa Drug Eluting Balloon For Peripheral Artery Disease Market Forecasts and Analysis - By Drug Coating Technology
9.4.4 Middle East and Africa Drug Eluting Balloon For Peripheral Artery Disease Market Forecasts and Analysis - By End-Users
9.4.5 Middle East and Africa Drug Eluting Balloon For Peripheral Artery Disease Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Drug Eluting Balloon For Peripheral Artery Disease Market
9.4.5.1.1 South Africa Drug Eluting Balloon For Peripheral Artery Disease Market by Drug Coating Technology
9.4.5.1.2 South Africa Drug Eluting Balloon For Peripheral Artery Disease Market by End-Users
9.4.5.2 Saudi Arabia Drug Eluting Balloon For Peripheral Artery Disease Market
9.4.5.2.1 Saudi Arabia Drug Eluting Balloon For Peripheral Artery Disease Market by Drug Coating Technology
9.4.5.2.2 Saudi Arabia Drug Eluting Balloon For Peripheral Artery Disease Market by End-Users
9.4.5.3 U.A.E Drug Eluting Balloon For Peripheral Artery Disease Market
9.4.5.3.1 U.A.E Drug Eluting Balloon For Peripheral Artery Disease Market by Drug Coating Technology
9.4.5.3.2 U.A.E Drug Eluting Balloon For Peripheral Artery Disease Market by End-Users
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Drug Eluting Balloon For Peripheral Artery Disease Market Overview
9.5.2 South and Central America Drug Eluting Balloon For Peripheral Artery Disease Market Forecasts and Analysis
9.5.3 South and Central America Drug Eluting Balloon For Peripheral Artery Disease Market Forecasts and Analysis - By Drug Coating Technology
9.5.4 South and Central America Drug Eluting Balloon For Peripheral Artery Disease Market Forecasts and Analysis - By End-Users
9.5.5 South and Central America Drug Eluting Balloon For Peripheral Artery Disease Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Drug Eluting Balloon For Peripheral Artery Disease Market
9.5.5.1.1 Brazil Drug Eluting Balloon For Peripheral Artery Disease Market by Drug Coating Technology
9.5.5.1.2 Brazil Drug Eluting Balloon For Peripheral Artery Disease Market by End-Users
9.5.5.2 Argentina Drug Eluting Balloon For Peripheral Artery Disease Market
9.5.5.2.1 Argentina Drug Eluting Balloon For Peripheral Artery Disease Market by Drug Coating Technology
9.5.5.2.2 Argentina Drug Eluting Balloon For Peripheral Artery Disease Market by End-Users
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. DRUG ELUTING BALLOON FOR PERIPHERAL ARTERY DISEASE MARKET, KEY COMPANY PROFILES
11.1. MEDTRONIC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. KONINKLIJKE PHILIPS N.V.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BD
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. COOK MEDICAL
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. MEDRAD, INC. (BAYER HEALTHCARE'S)
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. EUROCOR
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. CARDIONOVUM
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Medtronic
2. Koninklijke Philips N.V.
3. BD
4. Cook Medical
5. MEDRAD, INC. (Bayer HealthCare's)
6. Eurocor
7. Cardionovum

TIPRE00008457
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking